Friday, October 24, 2014
Shares in Taiwan pulled back Thursday, taking a pause from the strong showing a session earlier as turnover dropped further to a new low for the year amid caution on the further volatility of Wall Street and global equity markets, dealers said.
Australia and New Zealand Banking Group Ltd. (ANZ) has maintained its forecast of China's gross domestic product (GDP) growth at 7.5 percent for 2014, although the world's second-largest economy reported slower growth in the third quarter of the year.
Signaling her reign has reached a pivotal juncture, Yahoo CEO Marissa Mayer is trying to convince restless shareholders that the long-struggling Internet company is heading in the right direction.
AT&T said it gained 2 million wireless subscribers in the latest quarter, but most were from cheaper non-phone services such as tablets and Internet-connected cars.
Hyundai Motor Co. said Thursday its profit sank nearly 30 percent for the July-September quarter, hurt by a stronger South Korean currency and weak sales growth in its home market.
The U.S. government is now urging owners of nearly 8 million cars and trucks to have the air bags repaired because of potential danger to drivers and passengers. But the effort is being complicated by confusing information and a malfunctioning website.
Credit Suisse Group has posted a third-quarter profit that is more than double from a year ago, benefiting from cost cutting, emerging markets and services for wealthy clients.
British retail sales fell by 0.3 percent in September from the level in August as warm weather delayed purchases of autumn-style clothing, official data showed on Thursday.
Nokia appears to have turned around its fortunes after the sale of its ailing cellphone unit to Microsoft, reporting a third-quarter net profit of 747 million euros (US$950 million), from a loss of 91 million euros a year earlier. Sales grew 13 percent.
U.S. healthcare giant Johnson & Johnson on Wednesday said it would spend up to US$200 million to speed up and expand its Ebola vaccine program, with testing slated to begin in January.